DOI: 10.1128/AAC.02193-17
Article Information
PubMed
Published By
History
- Received October 26, 2017
- Returned for modification December 5, 2017
- Accepted June 22, 2018
- Published online September 24, 2018.
Copyright & Usage
Copyright © 2018 Ali et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Article Versions
- Accepted Manuscript version (July 23, 2018).
- You are viewing the most recent version of this article.
Author Information
- Ali Mohamed Alia,b,c,
- Melissa A. Pennya,b,
- Thomas A. Smitha,b,
- Lesley Workmand,e,
- Philip Sasif,
- George O. Adjeig,h,
- Francesca Aweekai,
- Jean-René Kiechelj,
- Vincent Jullienk,
- Marcus J. Rijkenl,
- Rose McGreadyl,m,
- Julia Mwesigwan,o,
- Kim Kristensenp,
- Kasia Stepniewskam,q,
- Joel Tarningm,q,r,
- Karen I. Barnesd,e,
- Paolo Dentid,
- for the WWARN Amodiaquine PK Study Group
- aSwiss Tropical and Public Health Institute, Basel, Switzerland
- bUniversity of Basel, Basel, Switzerland
- cIfakara Health Institute, Bagamoyo, Tanzania
- dDivision of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa
- eWorldWide Antimalarial Resistance Network (WWARN) Clinical Pharmacology and Southern African Regional Hub, University of Cape Town, Cape Town, South Africa
- fMuhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania
- gCentre for Tropical Clinical Pharmacology and Therapeutics, College of Health Sciences, University of Ghana, Korle Bu, Ghana
- hOffice of Research, Innovation and Development, University of Ghana, Legon, Ghana
- iDepartment of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, California, USA
- jDrugs for Neglected Diseases Initiative, Geneva, Switzerland
- kService de Pharmacologie, Hôpital Européen George Pompidou, Université Paris Descartes, Paris, France
- lShoklo Malaria Research Unit, Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand
- mCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
- nMedical Research Council Unit, Fajara, the Gambia
- oFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
- pDevelopment DMPK-PKPD, Novo Nordisk, Copenhagen, Denmark
- qWorldwide Antimalarial Resistance Network, University of Oxford, Oxford, United Kingdom
- rMahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
- Address correspondence to Paolo Denti, paolo.denti{at}uct.ac.za.
Citation Ali AM, Penny MA, Smith TA, Workman L, Sasi P, Adjei GO, Aweeka F, Kiechel J-R, Jullien V, Rijken MJ, McGready R, Mwesigwa J, Kristensen K, Stepniewska K, Tarning J, Barnes KI, Denti P, for the WWARN Amodiaquine PK Study Group. 2018. Population pharmacokinetics of the antimalarial amodiaquine: a pooled analysis to optimize dosing. Antimicrob Agents Chemother 62:e02193-17. https://doi.org/10.1128/AAC.02193-17.
